Xiaofeng Chen
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 9
- Cancer, Hypoxia, and Metabolism 1
-
- Circular RNAs in diseases 7
- RNA modifications and cancer 2
- RNA Research and Splicing 1
- Co-authors
- Heyong Wang (2 shared papers)Mingchuan Zhao (2 shared papers)Yongqian Shu (1 shared paper)Rong Wang (1 shared paper)Yingchao Zhu (1 shared paper)Liang Tang (1 shared paper)Gentao Liu (1 shared paper)Chunlian Wu (1 shared paper)
- Journals
- Journal of Cellular Biochemistry (1 paper)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)Cancer Letters (1 paper)OncoTargets and Therapy (1 paper)Neuro-Oncology (1 paper)
- Partner nations
- ChinaSaudi ArabiaUnited States
In The Last Decade
Xiaofeng Chen
11 papers receiving 507 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 386
- Molecular Biology 393
- Oncology 62
- Genetics 16
- Pathology and Forensic Medicine 21
Countries citing papers authored by Xiaofeng Chen
This map shows the geographic impact of Xiaofeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Chen more than expected).
Fields of papers citing papers by Xiaofeng Chen
This network shows the impact of papers produced by Xiaofeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Chen. The network helps show where Xiaofeng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofeng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 113 | |
| 2 | 2013 | 109 | |
| 3 | 2013 | 70 | |
| 4 | 2014 | 50 | |
| 5 | Prediction of non-small cell lung cancer metastasis-associated microRNAs using bioinformatics. | 2015 | 44 |
| 6 | 2018 | 44 | |
| 7 | 2009 | 31 | |
| 8 | 2016 | 20 | |
| 9 | MicroRNA-214 inhibits the proliferation and invasion of lung carcinoma cells by targeting JAK1. | 2018 | 20 |
| 10 | 2018 | 11 | |
| 11 | 2018 | 2 | |
| 12 | 2025 | 0 |
About Xiaofeng Chen
Xiaofeng Chen is a scholar working on Cancer Research, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 12 papers that have together received 514 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (7 papers), RNA modifications and cancer (2 papers), Lipoproteins and Cardiovascular Health (1 paper), RNA Research and Splicing (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Cancer Research (386 citations), Molecular Biology (393 citations), Oncology (62 citations), Genetics (16 citations) and Pathology and Forensic Medicine (21 citations). Xiaofeng Chen has collaborated with scholars based in China, Saudi Arabia and United States. Frequent co-authors include Heyong Wang, Mingchuan Zhao, Yongqian Shu, Rong Wang, Yingchao Zhu, Liang Tang, Gentao Liu, Chunlian Wu, Peng Zhang and Yaoqin Yang. Their work appears in journals such as Journal of Cellular Biochemistry, Clinical Chemistry and Laboratory Medicine (CCLM), Cancer Letters, OncoTargets and Therapy and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.